Back
Unity Software Vs. Akero Therapeutics Industry Stock Comparison
Sell
35
U
Unity Software
Last Price:
26.77
Seasonality Move:
-1.47%
Buy
57
AKRO
Akero Therapeutics
Last Price:
25.24
Seasonality Move:
12.31%
Sell
35
Unity Software (U)
is a Sell
Is Unity Software a Buy, Sell or Hold?
- The current Unity Software [U] share price is $26.99. The Score for U is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- U is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $25.23. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
U Stock Price Chart
What is Unity Software's stock price today?
-
The Unity Software share price today is $26.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and U is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $25.23
The current trend is relatively stagnant and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
U Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.11 | Sell |
Relative Strength Index (14 RSI): | 41.28 | Sell |
Chaikin Money Flow: | 8549439 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | 455217 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.97 - 29.43) | Sell |
Bollinger Bands (100): | (17.55 - 26.09) | Buy |
U Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.83 | Buy |
20-day SMA: | 26.98 | Buy |
50-day SMA: | 30.48 | Sell |
200-day SMA: | 34.11 | Sell |
8-day EMA: | 26.91 | Buy |
20-day EMA: | 27.61 | Sell |
50-day EMA: | 29.77 | Sell |
200-day EMA: | 33.04 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.04 | Buy |
20-day SMA: | 27.46 | Sell |
50-day SMA: | 24.28 | Buy |
200-day SMA: | 31.51 | Sell |
8-day EMA: | 25.3 | Sell |
20-day EMA: | 25.93 | Sell |
50-day EMA: | 24.97 | Buy |
200-day EMA: | 28.7 | Sell |
Unity Software Earnings Growth & U Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.05 per share, and an increase next year of $0.38 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.
Unity Software Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |